CIK 0001498382
- Non-accelerated filer
- Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 990360497
- Phone
- +1 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- 4 Other acquisition Chief Financial Officer acquired 211 shares (other)
- 4 Other acquisition Director acquired 528 shares (other)
- 4 Other acquisition Director acquired 71 shares (other)
- 4 Other acquisition Chief Scientific Officer acquired 169 shares (other)
- 4 Other acquisition Director acquired 282 shares (other)
- 4 Other acquisition Director acquired 176 shares (other)
- 4 Other acquisition Chief Scientific Officer acquired 169 shares (other)
- 4 Other acquisition Director acquired 176 shares (other)
- 4 Other acquisition Director acquired 282 shares (other)
- 4 Other acquisition Director acquired 71 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 211 shares (other)
- 4 Other acquisition Director acquired 74 shares (other)
- 4 Other acquisition Director acquired 528 shares (other)
- 4 Open-market buy Director bought 20,000 shares at $0.81 ($16,200)
- 4 Open-market buy Interim CEO bought 60,900 shares at an average $0.82 ($50,056)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 10,000 shares at an average $0.87 ($8,725)
- 4 Open-market buy Chief Financial Officer bought 17,500 shares at $0.85 ($14,910)
- 4 Other acquisition CEO acquired 176 shares (other)
- 4 Other acquisition Director acquired 282 shares (other)
Page 9 of 16 · 307 filings